Randomized, Double-Blind, Multicenter Trial of Hydrogen Water for Parkinson's Disease

Mov Disord. 2018 Sep;33(9):1505-1507. doi: 10.1002/mds.27472. Epub 2018 Sep 12.

Publication types

  • Letter
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Antiparkinson Agents / therapeutic use*
  • Double-Blind Method
  • Female
  • Humans
  • Hydrogen / therapeutic use*
  • Japan
  • Male
  • Middle Aged
  • Parkinson Disease / drug therapy*
  • Severity of Illness Index
  • Treatment Outcome
  • Water

Substances

  • Antiparkinson Agents
  • Water
  • Hydrogen